# A Pilot Bioequivalence Study of Pomalidomide

> **NCT06058689** · PHASE1 · UNKNOWN · sponsor: **Megalabs** · enrollment: 10 (estimated)

## Conditions studied

- Bioequivalence Study

## Interventions

- **DRUG:** Pomalidomide 4 MG Oral Capsule

## Key facts

- **NCT ID:** NCT06058689
- **Lead sponsor:** Megalabs
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-09-15
- **Primary completion:** 2024-11-15
- **Final completion:** 2025-03-15
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06058689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06058689, "A Pilot Bioequivalence Study of Pomalidomide". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06058689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*